| Stage | NUTX | % of rev | V | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $211M | 100.00% | $11.6B | 100.00% | V ×55.20 |
| Gross profit | $141M | 67.04% | $9.2B | 78.87% | V +11.8pp |
| Operating income | $122M | 57.75% | $6.9B | 59.12% | V +1.4pp |
| Pre-tax income | $117M | 55.56% | $6.8B | 58.74% | V +3.2pp |
| Net income | $96M | 45.70% | $5.6B | 48.38% | V +2.7pp |
| Stage | NUTX | V | Gap · A − B |
|---|---|---|---|
| Revenue | $211M100.00% | $11.6B100.00% | V ×55.20 |
| Gross profit | 67.04%$141M | 78.87%$9.2B | V +11.8pp |
| Operating income | 57.75%$122M | 59.12%$6.9B | V +1.4pp |
| Pre-tax income | 55.56%$117M | 58.74%$6.8B | V +3.2pp |
| Net income |
| 45.70%$96M |
| 48.38%$5.6B |
| V +2.7pp |
No shared counterparties.